CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.19B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.92: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.67%Below 5Y avg (2.50%)
Annual Rate
CNY 0.30Paid annual
Payout Ratio
21.4%Sustainable
Payback Period
59.9 yr
Last Ex-Dividend
Jul 8, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
21.50BCNY3.19B · vs all stocks (USD)
Trailing P/E
7.68xRevenue (TTM)
2.23BCNY330.21M · vs all stocks (USD)
Profit Margin
123.25%Beta
0.5040xvs all stocks
52-Week Change
-10.46%vs all stocks
Market Capitalization
21.50BCNY3.19B · vs all stocks (USD)
Enterprise Value
20.91BCNY3.10B · vs all stocks (USD)
Trailing P/E
7.68xForward P/E
8.24xPrice to Sales (TTM)
9.65xPrice to Book (MRQ)
0.6689xEnterprise to Revenue
9.39xGross Margin
48.42%Profit Margin
123.25%Operating Margin
4.46%Return on Assets (TTM)
-0.27%Return on Equity (TTM)
8.83%Revenue (TTM)
2.23BCNY330.21M · vs all stocks (USD)
Revenue per Share (TTM)
1.90CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-17.40%Gross Profit (TTM)
1.02BCNY151.26M · vs all stocks (USD)
EBITDA (TTM)
2.63BCNY389.49M · vs all stocks (USD)
Net Income (TTM)
2.74BCNY406.99M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
67.60%Operating Cash Flow (TTM)
227.01MCNY33.67M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
76.48MCNY11.34M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3000CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
1.67%vs all stocks
5-Year Average Dividend Yield
2.50%vs all stocks
Payout Ratio
21.36%Minority Interest (Equity)
220.23MCNYFY2025 · Dec 31, 2025Revenue
2.34BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.21BCNYFY2025 · Dec 31, 2025Gross Profit
1.13BCNYFY2025 · Dec 31, 2025Operating Income
-62.86MCNY-9.32M · vs all stocks (USD)
Pre-tax Income
2.42BCNYFY2025 · Dec 31, 2025Income Tax Expense
59.32MCNYFY2025 · Dec 31, 2025Net Income
2.36BCNYFY2025 · Dec 31, 2025EBIT
2.47BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.76BCNYFY2025 · Dec 31, 2025Research & Development
101.91MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
781.83MCNYFY2025 · Dec 31, 2025Other Operating Expenses
41.72MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
52.26MCNYFY2025 · Dec 31, 2025EPS (Basic)
2.04CNYFY2025 · Dec 31, 2025EPS (Diluted)
2.04CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.17BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.17BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.36BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
33.97MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
2.61BCNYFY2025 · Dec 31, 2025Free Cash Flow
2.49BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.15BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.36BCNYFY2025 · Dec 31, 2025Other Non-cash Items
68.21MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
76.79MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
106.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-123.29MCNYFY2025 · Dec 31, 2025Net Acquisitions
-1.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-2.32BCNYFY2025 · Dec 31, 2025Sale of Investments
3.05BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
610.41MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.06BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.12BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-649.03MCNYFY2025 · Dec 31, 2025Other Financing Charges
-122.12MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-834.69MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.20BSharesUpdated Aug 18, 2026Float Shares
807.30MSharesUpdated Aug 18, 2026% Held by Insiders
32.41%vs all stocks
% Held by Institutions
8.48%vs all stocks
Total Cash (MRQ)
2.90BCNY429.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.47CNYUpdated Aug 18, 2026Total Debt (MRQ)
2.25BCNY333.54M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0709xCurrent Ratio (MRQ)
2.38xBook Value per Share (MRQ)
26.86CNYUpdated Aug 18, 2026Total Assets
34.42BCNY5.10B · vs all stocks (USD)
Total Current Assets
4.82BCNYFY2025 · Dec 31, 2025Total Liabilities
3.53BCNYFY2025 · Dec 31, 2025Total Non-current Assets
29.59BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.52BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.01BCNYFY2025 · Dec 31, 2025Cash
1.15BCNYFY2025 · Dec 31, 2025Cash Equivalents
9.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.16BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.80BCNYFY2025 · Dec 31, 2025Accounts Receivable
666.79MCNYFY2025 · Dec 31, 2025Inventory
802.10MCNYFY2025 · Dec 31, 2025Accounts Payable
310.42MCNYFY2025 · Dec 31, 2025Short-term Debt
936.38MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.94MCNYFY2025 · Dec 31, 2025Long-term Debt
1.30BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.20BCNYFY2025 · Dec 31, 2025Retained Earnings
21.34BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
30.89BCNY4.58B · vs all stocks (USD)
Treasury Stock
420.01MCNYFY2025 · Dec 31, 202552-Week Low
16.36CNYUpdated Aug 18, 202652-Week High
22.08CNYUpdated Aug 18, 202652-Week Change
-10.46%vs all stocks
Beta
0.5040xvs all stocks
50-Day MA
17.96CNYUpdated Aug 18, 2026200-Day MA
18.70CNYUpdated Aug 18, 2026Avg 10-Day Volume
12.50MSharesUpdated Aug 18, 2026Avg 30-Day Volume
14.96MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
2.34CNYUpdated Aug 18, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 406,994,501.018Operating Cash Flow (USD, TTM): 33,666,190.437
Financial Health
Altman Z-Score 4.92: safe zoneNotable
Altman Z-Score: 4.92
High structural barrier to entryNotable
Barrier to Entry: 0.84
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.19B, above the global median of $1.15BNotable
Market cap (USD): 3,188,776,120.301Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
ABL Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Betta Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Integer Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRule
Wockhardt Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hybio Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BioArctic AB
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai Haoyuan Chemexpress Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lepu Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
MBX Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Aurinia Pharmaceuticals Inc.
2 interpretationsMinimal Tax and Interest DragMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Actions Technology Co., Ltd.
2 interpretationsMinimal Tax and Interest DragMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
SM Entertainment Co., Ltd.
2 interpretationsMinimal Tax and Interest DragMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities